TEIJIN LIMITED (3401.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−32.2x

Market Cap

JPY 342.98B

MomentumView details →

1D Return

+0.65%

YTD Return

+28.14%

RSI (14)

50.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−32.2x

Market Cap

JPY 342.98B

RSI (14)

50.2

MomentumView details →

1D Return

+0.65%

YTD Return

+28.14%

ProfitabilityView details →

Gross Margin

18.55%

Net Margin

−10.08%

EBITDA Margin

−1.19%

ROE (TTM)

−23.87%

ROA (TTM)

−9.56%

Asset Turnover

0.91x

GrowthView details →

Revenue YoY

−13.16%

EPS YoY

—

FCF YoY

+262.69%

Revenue CAGR 3Y

−5.01%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.84x

Current Ratio

1.75x

Quick Ratio

1.06x

Div Yield

2.81%

Div Rate

JPY 50.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

873.19B

Net Income (TTM)

−88.00B

Op. CF (TTM)

98.65B

Next earningsNov 9, 2026 →

Latest newsMore news →

Teijin announced it has signed a technology advisory contract with Professor Dario Campana of the National University of Singapore to enhance its regenerative medicine CDMO business.17d ago

Similar companies

UBE Corporation4208.T KOSE Holdings Corporation4922.T NIPPON KAYAKU CO.,LTD.4272.T KANEKA CORPORATION4118.T C.Uyemura & Co.,Ltd.4966.T POLA ORBIS HOLDINGS INC.4927.T Find similar companies →

Latest newsMore news →

Teijin announced it has signed a technology advisory contract with Professor Dario Campana of the National University of Singapore to enhance its regenerative medicine CDMO business.17d ago